Facebook
Twitter
Telegram
Report an ErrorXenon Pharmaceuticals Financial Statements 2011-2024 | XENE
Annual Financial Statements Xenon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.13 B | 2.45 B | 1.18 B | 496 M | 387 M | 159 M | 55.8 M | 125 M | 94.4 M | 56.3 M | - | - | - |
Shares |
66.9 M | 60.5 M | 43.6 M | 34.5 M | 25.9 M | 19.4 M | 18 M | 15.5 M | 14.3 M | 3.17 M | - | - | - |
Historical Prices |
46.8 | 40.5 | 27.1 | 14.3 | 14.6 | 8.54 | 3.2 | 8.2 | 6.61 | 17.8 | - | - | - |
Net Income |
-182 M | -125 M | -78.9 M | -28.8 M | -41.6 M | -34.5 M | -30.7 M | -23 M | -15.8 M | 13 M | 12 M | -4.3 M | -12 M |
Revenue |
- | 9.43 M | 18.4 M | 32.2 M | 6.83 M | - | 311 K | 1.8 M | 15.6 M | 28.4 M | 27.4 M | 14.3 M | 6.92 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 6.83 M | -6 M | - | - | - | - | - | - | - |
Operating Income |
-214 M | -129 M | -79 M | -31.3 M | -42.8 M | -38 M | -32.6 M | -24.8 M | -9.36 M | 11.1 M | 9.71 M | -3.15 M | - |
Interest Expense |
- | - | - | 484 K | 1.43 M | 1.39 M | - | - | - | - | 64 K | 93 K | - |
EBITDA |
-211 M | -128 M | -78.1 M | -30.7 M | -42.4 M | -37.4 M | -31.9 M | -24 M | -8.32 M | 11.8 M | 10.4 M | -2.37 M | -11 M |
Operating Expenses |
214 M | 139 M | 97.4 M | 63.5 M | 49.6 M | 32 M | 32.9 M | 26.6 M | 24.9 M | 17.3 M | - | - | - |
General and Administrative Expenses |
46.5 M | 32.8 M | 22 M | 12.9 M | 10.8 M | 8.38 M | 7.31 M | 6.79 M | 9.79 M | 5.5 M | 5.34 M | 7.01 M | 6.73 M |
All numbers in USD currency
Quarterly Income Statement Xenon Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
77.6 M | 75.4 M | 66 M | 65.9 M | 65.7 M | 62.6 M | 65.5 M | 56.2 M | 54.9 M | 51.6 M | 42.3 M | 42.1 M | 36.8 M | 35 M | 35 M | 35 M | 33.2 M | 28.1 M | 25.8 M | 25.8 M | 25.8 M | 25.8 M | 20.3 M | 14.3 M | 17.8 M | 18 M | 18 M | 18 M | 17.9 M | 17.9 M | 15.3 M | 14.4 M | 14.4 M | 14.4 M | 14.3 M | 14.2 M | 14.2 M | 14.2 M | 1.35 M | 1.35 M | 1.35 M | 1.34 M | 1.34 M | - | - | - | - | - | - | - | - | - | - |
Net Income |
-47.9 M | - | -48.5 M | -47.5 M | -41.7 M | - | -37.2 M | -31.2 M | -19.7 M | - | -15.4 M | -22.1 M | -15.8 M | - | -8.86 M | -175 K | -7.48 M | - | -8.87 M | -10 M | -11.3 M | - | -14.4 M | -7.8 M | -3.76 M | -8.06 M | -30.7 M | -30.7 M | -30.7 M | -6 M | -23 M | -23 M | -23 M | -3.94 M | -15.8 M | -15.8 M | -15.8 M | 1.22 M | 13 M | 13 M | 13 M | 2.51 M | 12 M | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | 132 K | 536 K | 8.77 M | - | 8.12 M | 2.22 M | 4.36 M | - | 6.55 M | 13.4 M | 7.08 M | - | 3.5 M | - | - | - | - | - | - | 16 K | 264 K | 15 K | 16 K | 376 K | 413 K | 413 K | 601 K | 3.23 M | 4.29 M | 4.05 M | 4.01 M | 4.88 M | 13.2 M | 5.3 M | 5 M | 5.58 M | 10.8 M | 5.6 M | 5.38 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-59 M | - | -55.7 M | -55.6 M | -49.1 M | - | -38.1 M | -30.3 M | -17.4 M | - | -15.6 M | -22.5 M | -16.1 M | - | -9.7 M | -646 K | -8.03 M | - | -8.95 M | -10.5 M | -11.8 M | - | -14.2 M | -7.59 M | -7.81 M | -8.05 M | -8.64 M | -7.89 M | -7.99 M | -5.46 M | -7.33 M | -6.37 M | -5.66 M | -2.6 M | -820 K | 199 K | -6.14 M | 35 K | 8.66 M | 1.38 M | 1.03 M | 2.02 M | 6.52 M | -770 K | 1.94 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 484 K | 154 K | 330 K | - | 363 K | 365 K | 358 K | - | 678 K | 200 K | 159 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-58.4 M | - | - | - | -48.7 M | - | -37 M | -29.6 M | -17 M | - | -15 M | -22.1 M | -15.9 M | - | -9.26 M | -375 K | -7.93 M | - | -8.67 M | -10.3 M | -11.7 M | - | -13.7 M | -7.29 M | -7.66 M | -8.05 M | -8.14 M | -7.56 M | -7.82 M | -5.46 M | -6.63 M | -5.84 M | -5.38 M | -2.6 M | -66 K | 691 K | -5.93 M | 35 K | 9.19 M | 1.73 M | 1.21 M | 2.02 M | 7.05 M | -770 K | 1.94 M | - | - | - | - | - | - | - | - |
Operating Expenses |
59 M | - | 55.7 M | 55.6 M | 49.1 M | - | 38.3 M | 30.9 M | 26.1 M | - | 23.7 M | 24.7 M | 20.4 M | - | 16.3 M | 14 M | 15.1 M | - | 12.5 M | 10.5 M | 11.8 M | - | 14.2 M | 7.59 M | 7.81 M | - | 8.91 M | 7.91 M | 8 M | - | 7.74 M | 6.78 M | 6.26 M | - | 5.11 M | 3.85 M | 10.1 M | - | 4.53 M | 3.92 M | 3.97 M | - | 4.27 M | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
14.8 M | - | 12.8 M | 11.6 M | 9.54 M | - | 8.83 M | 8.7 M | 6.78 M | - | 4.83 M | 6.34 M | 4.11 M | - | 3.21 M | 3.31 M | 3.32 M | - | 2.7 M | 2.31 M | 2.62 M | - | 1.94 M | 2.18 M | 2.24 M | - | 1.74 M | 1.8 M | 2.1 M | - | 1.78 M | 1.68 M | 1.9 M | - | 1.32 M | 178 K | 6.72 M | - | 1.32 M | 1.21 M | 1.3 M | - | 1.69 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency